Literature DB >> 19602614

Oral health and inflammation in patients with end-stage renal failure.

Gulsen Bayraktar1, Idil Kurtulus, Rumeyza Kazancioglu, Isil Bayramgurler, Serdar Cintan, Canan Bural, Semra Bozfakioglu, Halim Issever, Alaattin Yildiz.   

Abstract

BACKGROUND/AIMS: End-stage renal disease (ESRD) patients have an increased risk of atherosclerotic complications. In both hemodialysis (HD) patients and the general population, it has become evident that inflammation plays an important role in the pathogenesis of atherosclerotic complications. Oral and dental problems in ESRD patients could be an important source of inflammation, thus treatment of these problems is important to protect these patients from potential infections. The decayed, missing, and filled teeth (DMFT) index is an indicator of oral and dental health status. Our aim was to analyze and compare salivary flow rate (SFR), salivary pH (SpH), salivary buffering capacity (SBC), and DMFT index and plaque index (PI) values in PD patients to HD patients and healthy controls (C) and establish the relationship between these parameters and C-reactive protein (CRP).
METHODS: 76 PD patients, 100 HD patients, and 111 Cs were included in the study. SFR (milliliters/minute) was measured in stimulated whole saliva, SpH was measured using the Merck indicator, and SBC was measured according to the method of Ericsson: 1 mL whole saliva was added to 3 mL 0.005 N HCl and a stream of air was passed through this mixture for 20 minutes. Finally, DMFT index and PI values were calculated.
RESULTS: No statistically significant differences were found in age or gender distribution among PD, HD, and C groups. There was also no significant difference in time on dialysis between PD and HD groups. SFR was significantly lower in the PD and HD groups than in the C group (1.30 +/- 0.83 and 0.70 +/- 0.32 vs 1.64 +/- 0.45 mL/min) and lower in the HD than in the PD group (p < 0.001). SpH (8.35 +/- 0.43 and 8.12 +/- 0.74 vs 7.16 +/- 0.76) and SBC (7.39 +/- 0.47 and 6.82 +/- 0.70 vs 5.08 +/- 0.73) were significantly higher in the PD and HD groups than in the C group and higher in the PD than in the HD group (p < 0.05 and p < 0.001 respectively). The numbers of filled teeth were significantly higher in the PD than in the HD and C groups (p < 0.001). DMFT index was significantly higher in the PD than in the HD group (p < 0.001). Finally, PI values were significantly higher in the PD and HD groups than in the C group (p < 0.001) and higher in the HD than in the PD group, although this was not statistically significant. In the present study, we also found higher CRP values in HD than in PD patients and a positive correlation between CRP and PI values in PD patients.
CONCLUSIONS: PD patients have higher SFR, SpH, and SBC values than HD patients; however, higher DMFT index and higher numbers of filled teeth were observed in PD patients. Compared to healthy controls, patients on dialysis had worse dental and periodontal findings, which might have a role in microinflammation in this group of patients.

Entities:  

Mesh:

Year:  2009        PMID: 19602614

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  21 in total

1.  Assessment of oral health in peritoneal dialysis patients with and without diabetes mellitus.

Authors:  Abubekir Eltas; Ummühan Tozoğlu; Mustafa Keleş; Varol Canakci
Journal:  Perit Dial Int       Date:  2011-05-31       Impact factor: 1.756

Review 2.  Nutrition in patients on peritoneal dialysis.

Authors:  Seung-Hyeok Han; Dae-Suk Han
Journal:  Nat Rev Nephrol       Date:  2012-02-07       Impact factor: 28.314

3.  An ignored cause of inflammation in patients undergoing continuous ambulatory peritoneal dialysis: periodontal problems.

Authors:  Ismail Kocyigit; Hasan Esat Yucel; Omer Cakmak; Fatma Dogruel; Dürdane Banu Durukan; Hafsa Korkar; Aydin Unal; Murat Hayri Sipahioglu; Oktay Oymak; Cem A Gurgan; Bulent Tokgoz
Journal:  Int Urol Nephrol       Date:  2014-04-23       Impact factor: 2.370

4.  Periodontal disease in chronic kidney disease and end-stage renal disease patients: a review.

Authors:  Venkatesh K Ariyamuthu; Karl D Nolph; Bruce E Ringdahl
Journal:  Cardiorenal Med       Date:  2013-04       Impact factor: 2.041

Review 5.  Xerostomia in patients on chronic hemodialysis.

Authors:  Maurizio Bossola; Luigi Tazza
Journal:  Nat Rev Nephrol       Date:  2012-01-17       Impact factor: 28.314

Review 6.  Salivary changes in chronic kidney disease and in patients undergoing hemodialysis: a systematic review and meta-analysis.

Authors:  Renata Prata Cunha Bernardes Rodrigues; Maria Tereza Campos Vidigal; Walbert A Vieira; Gustavo G Nascimento; Robinson Sabino-Silva; Cauane Blumenberg; Michelle F Siqueira; Walter L Siqueira; Luiz Renato Paranhos
Journal:  J Nephrol       Date:  2022-03-02       Impact factor: 4.393

7.  Knowledge and awareness of medical doctors, medical students and nurses about dentistry in Nigeria.

Authors:  Elijah Olufemi Oyetola; Taiwo Oyewole; Micheal Adedigba; Stephen Tunde Aregbesola; Kehinde Umezudike; Adedotun Adewale
Journal:  Pan Afr Med J       Date:  2016-04-07

8.  Evaluation of changes in salivary composition in renal failure patients before and after hemodialysis.

Authors:  Nishath Khanum; Mahesh Mysore-Shivalingu; Srisha Basappa; Archana Patil; Santosh Kanwar
Journal:  J Clin Exp Dent       Date:  2017-11-01

9.  The Relationship between Salivary Beta-2 Microglobulin and Uremia Intensity in Men with Chronic Renal Failure.

Authors:  Mohammad Vahedi; Hossein Malekzadeh; Habib Haybar; Ali Reza Soltanian; Shermin Abdollahzadeh; Hojjat Yoosefi; Masoud Seyedian; Leila Yazdanpanah; Abrotan Saeid; Maryam Shabanpour Fooladi; Marziyeh Ghasemi
Journal:  Cell J       Date:  2013-02-20       Impact factor: 2.479

10.  Salivary creatinine estimation as an alternative to serum creatinine in chronic kidney disease patients.

Authors:  Ramesh Venkatapathy; Vasupradha Govindarajan; Nirima Oza; Sreejith Parameswaran; Balamurali Pennagaram Dhanasekaran; Karthikshree V Prashad
Journal:  Int J Nephrol       Date:  2014-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.